Editas Medicine Statistics

Total Valuation

Editas Medicine has a market cap or net worth of GBP 87.00 million. The enterprise value is -95.30 million.

Market Cap	87.00M
Enterprise Value	-95.30M

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+12.94%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	77.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.61
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.67

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.22.

Current Ratio	3.75
Quick Ratio	3.67
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.56% and return on invested capital (ROIC) is -46.89%.

Return on Equity (ROE)	-78.56%
Return on Assets (ROA)	-34.32%
Return on Invested Capital (ROIC)	-46.89%
Return on Capital Employed (ROCE)	-89.54%
Revenue Per Employee	173,881
Profits Per Employee	-592,860
Employee Count	265
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.61%
50-Day Moving Average	1.64
200-Day Moving Average	3.75
Relative Strength Index (RSI)	42.99
Average Volume (20 Days)	27,444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.02

Income Statement

In the last 12 months, Editas Medicine had revenue of GBP 46.08 million and -157.11 million in losses. Loss per share was -1.91.

Revenue	46.08M
Gross Profit	-118.21M
Operating Income	-170.50M
Pretax Income	-157.11M
Net Income	-157.11M
EBITDA	-166.10M
EBIT	-170.50M
Loss Per Share	-1.91

Full Income Statement

Balance Sheet

The company has 197.78 million in cash and 28.72 million in debt, giving a net cash position of 169.07 million.

Cash & Cash Equivalents	197.78M
Total Debt	28.72M
Net Cash	169.07M
Net Cash Per Share	n/a
Equity (Book Value)	131.04M
Book Value Per Share	1.59
Working Capital	148.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -135.61 million and capital expenditures -7.16 million, giving a free cash flow of -142.77 million.

Operating Cash Flow	-135.61M
Capital Expenditures	-7.16M
Free Cash Flow	-142.77M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-256.53%
Operating Margin	-370.02%
Pretax Margin	-340.96%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Editas Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.94%
Shareholder Yield	-12.94%
Earnings Yield	-180.59%
FCF Yield	-164.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Editas Medicine has an Altman Z-Score of -5.28. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.28
Piotroski F-Score	n/a